Cirius Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 14, 2017
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Traction
- Actively enrolling patients in a Phase 2b clinical trial.
- Company Description
- Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
- Market
- Liver Disease Treatment
- Location
- Kalamazoo, Michigan, USA
- Coinvestors
- Adams Street Partners, Frazier Healthcare, Novo A/S, Renaissance Venture Capital Fund